ARQT

Arcutis Biotherapeutics, Inc.

ARQT·NasdaqGS

FollowCompareShare

26.58+2.09 (+8.53%)today

At close: Oct 9, 4:00 PM EDT · Real-time · USD

After hours26.580.00 (0.00%)Oct 9, 4:00 PM EDT

1D5D1M6MYTD1Y5YMAX

MountainLineCandles

Indicators

Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close24.49

Open24.50

Day range24.3026.97

52-week range19.3031.77

Volume1.73M

Avg. volume (3M)2.23M

Market cap3.34B

P/E ratio (TTM)120.82

Forward P/E19.54

EPS (TTM)0.2200

Dividend yield—

Beta (5Y)—

Shares outstanding125.69M

Earnings dateAug 5, 2026

Analyst target—

Profit margin—

Latest news

All ARQT news ›

Yahoo Finance·7h ago

Arcus Biosciences, Inc. (RCUS)

Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Arcus Biosciences, Inc. (RCUS) Arcus Biosciences, Inc. Overview Biotechnology / Healthcare Arcus Biosciences, Inc., a clinical-stage biopharmaceutical…

Markets Daily·13h ago

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Has Consensus Price Target of $35.57 According to Analysts

Posted by Danessa Lincoln on Oct 10th, 2026 View Our Latest Report on ARQT ARQT opened at $26.58 on Friday. The company has a 50 day moving average of $25.33 and a 200 day moving average of $24.63. The company has a market cap of $3.34…

Seeking Alpha·4d ago

Arcutis Biotherapeutics: An Emerging GARP Stock

(NASDAQ:ARQT) Seeking Alpha - Arcutis Biotherapeutics is rated 'Accumulate' as it rapidly transitions to profitability, driven by robust ZORYVE franchise expansion. - FY2026 sales guidance was raised to $525–$540 million, reflecting strong…

@StockTitan_net·3d ago

Connect Biopharma: Leonard reports 6.77% stake

A holder reports sole voting power over 400,000 Connect Biopharma (CNTB) shares, plus shared ownership. Stock Titan - [SCHEDULE 13G] Connect Biopharma Holdings Ltd Passive Investment Disclosure (>5%) Connect Biopharma: Leonard reports…

@StockTitan_net·4d ago

Outset Medical: BML reports 14.7% passive stake

A partnership reports shared voting power over 2.76M Outset Medical (OM) shares. Stock Titan - [SCHEDULE 13G/A] Outset Medical, Inc. Amended Passive Investment Disclosure Outset Medical: BML reports 14.7% passive stake The reported…

Stock Titan·Sep 23

Perspective Therapeutics: Lantheus holds 7.7% stake

Perspective Therapeutics (CATX) is a radiopharmaceutical development company focused on 212Pb-based theranostic treatments and imaging for multiple cancer types. - [SCHEDULE 13D/A] Perspective Therapeutics, Inc. Amended Major Shareholder…

From articles in the 4Search news index.

In the news

6mentions in 30 days

Mixedheadline tone

Mentioned with

Advisorshares Trust2Arcutis Biotherapeutics, Inc2Arcutis Biotherapeutics, Inc.2BlackRock2Btig Research2Eli Lilly2Halper Sadeh Llc2Johnson & Johnson2

People in the coverage

Kim Johansen5Danessa Lincoln3Sarita Garza3Leonard2Marketbeat2Matthew D. Perry2

Themes

Healthcare5Biotechnology4SEC Filings3All News and Stock Ideas2Beneficial Ownership2Common Stock2Earnings2Financial2

Most coverage from

1. stocktitan.net3
2. ca.finance.yahoo.com1
3. seekingalpha.com1
4. themarketsdaily.com1

Measured across the 4Children news index. Headline tone is a simple word-based reading of the latest 6 headlines, not a forecast.

Market data is provided for information only and comes from free public sources. Quotes are marked real-time or delayed as their source reports them; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Children index. Terms of use.